• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒与恶性疟原虫之间是否存在相互作用?

Is there an interaction between human immunodeficiency virus and Plasmodium falciparum?

作者信息

Chandramohan D, Greenwood B M

机构信息

Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK.

出版信息

Int J Epidemiol. 1998 Apr;27(2):296-301. doi: 10.1093/ije/27.2.296.

DOI:10.1093/ije/27.2.296
PMID:9602413
Abstract

BACKGROUND

There is a potential for interaction between malaria and human immunodeficiency virus (HIV) infection. HIV infection might reduce immunity to malaria resulting in more frequent and severe infections; conversely malaria might enhance the progression of HIV infection to AIDS. In this paper we have reviewed some of the studies that have addressed this topic.

METHODS

Studies identified by a MEDLINE search were systematically reviewed and the measures of association between the two infections were either abstracted or recalculated from the reported data. Inferences drawn from these studies and the biological plausibility of an interaction are discussed.

RESULTS

The prevalence ratio (PR) of peripheral parasitaemia among HIV seropositive (HIVSP) individuals compared to HIV seronegative (HIVSN) individuals ranged from 0.72 to 0.94 in children and from 3.3 to 0.69 in adults. However, only one study showed a statistically significant difference between HIVSP and HIVSN groups (PR 3.3, 95% CI: 2.7-4.2). The rate ratio of non-severe malaria among HIVSP children compared to HIVSN children was 1.4 (95% CI: 0.99-2.0). Data from a trial of chemoprophylaxis during pregnancy suggested that placental malaria may predispose to perinatal transmission of HIV. Studies that have investigated the immune response to P. falciparum among HIVSP subjects have given variable results.

CONCLUSION

There is no convincing evidence for an interaction between malaria and HIV with the possible exception of an interaction between placental malaria and HIV infection. Several studies, however, had potentials for bias and/or an inadequate sample size. There is a need for carefully designed studies to resolve whether mortality from severe malaria, in particular cerebral malaria, is increased in HIVSP subjects, whether malaria infection of the placenta increases the risk of vertical transmission of HIV, and whether malaria infection increases the progression of HIV infection to AIDS.

摘要

背景

疟疾与人类免疫缺陷病毒(HIV)感染之间存在相互作用的可能性。HIV感染可能会降低对疟疾的免疫力,导致感染更加频繁和严重;相反,疟疾可能会加速HIV感染向艾滋病的进展。在本文中,我们回顾了一些针对该主题的研究。

方法

对通过MEDLINE检索确定的研究进行系统回顾,并从报告的数据中提取或重新计算两种感染之间的关联指标。讨论了从这些研究中得出的推论以及相互作用的生物学合理性。

结果

与HIV血清阴性(HIVSN)个体相比,HIV血清阳性(HIVSP)个体外周血寄生虫血症的患病率比值(PR)在儿童中为0.72至0.94,在成人中为3.3至0.69。然而,只有一项研究显示HIVSP组和HIVSN组之间存在统计学上的显著差异(PR 3.3,95%置信区间:2.7 - 4.2)。与HIVSN儿童相比,HIVSP儿童中非重症疟疾的发病率比值为1.4(95%置信区间:0.99 - 2.0)。一项孕期化学预防试验的数据表明,胎盘疟疾可能易导致HIV的围产期传播。对HIVSP受试者中恶性疟原虫免疫反应的研究结果各不相同。

结论

除胎盘疟疾与HIV感染之间可能存在相互作用外,没有令人信服的证据表明疟疾与HIV之间存在相互作用。然而,几项研究存在偏倚可能性和/或样本量不足的问题。需要精心设计的研究来确定HIVSP个体中严重疟疾(特别是脑型疟疾)的死亡率是否增加、胎盘疟疾感染是否会增加HIV垂直传播的风险以及疟疾感染是否会加速HIV感染向艾滋病的进展。

相似文献

1
Is there an interaction between human immunodeficiency virus and Plasmodium falciparum?人类免疫缺陷病毒与恶性疟原虫之间是否存在相互作用?
Int J Epidemiol. 1998 Apr;27(2):296-301. doi: 10.1093/ije/27.2.296.
2
Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children.扎伊尔金沙萨的恶性疟原虫疟疾与围产期获得的1型人类免疫缺陷病毒感染。对587名儿童进行的前瞻性纵向队列研究。
N Engl J Med. 1991 Jul 11;325(2):105-9. doi: 10.1056/NEJM199107113250206.
3
Effect of HIV-1 Serostatus on the Prevalence of Asymptomatic Plasmodium falciparum Parasitemia Among Children Less Than 5 Years of Age in Benin City, Nigeria.尼日利亚贝宁城5岁以下儿童中HIV-1血清状态对无症状恶性疟原虫血症患病率的影响。
J Pediatric Infect Dis Soc. 2016 Mar;5(1):21-8. doi: 10.1093/jpids/piu093. Epub 2014 Oct 17.
4
Impact of Plasmodium falciparum malaria and intermittent preventive treatment of malaria in pregnancy on the risk of malaria in infants: a systematic review.恶性疟原虫疟疾和孕妇间歇性预防治疗疟疾对婴儿疟疾风险的影响:系统评价。
Malar J. 2019 Sep 3;18(1):304. doi: 10.1186/s12936-019-2943-3.
5
Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire.扎伊尔金沙萨儿童中恶性疟原虫疟疾与人类免疫缺陷病毒感染之间无关联。
Bull World Health Organ. 1987;65(5):607-13.
6
Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life.母亲感染恶性疟原虫的胎盘感染情况及儿童出生后头两年的疟疾发病率
Am J Epidemiol. 1997 Nov 15;146(10):826-31. doi: 10.1093/oxfordjournals.aje.a009200.
7
Epidemiology and burden of malaria in pregnancy.孕期疟疾的流行病学与负担
Lancet Infect Dis. 2007 Feb;7(2):93-104. doi: 10.1016/S1473-3099(07)70021-X.
8
Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.复方新诺明预防撒哈拉以南非洲地区 HIV 阳性孕妇中恶性疟原虫疟疾的效果:一项开放标签、随机对照试验。
Clin Infect Dis. 2014 Mar;58(5):651-9. doi: 10.1093/cid/cit806. Epub 2013 Dec 12.
9
The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya.肯尼亚西部艾滋病毒与疟疾双重感染对妊娠结局的影响。
AIDS. 2003 Mar 7;17(4):585-94. doi: 10.1097/00002030-200303070-00014.
10
HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya.在肯尼亚基苏木,感染艾滋病毒会增加所有妊娠阶段女性感染疟疾的风险。
AIDS. 2003 Mar 7;17(4):595-603. doi: 10.1097/00002030-200303070-00015.

引用本文的文献

1
Drug-drug interaction between dolutegravir and artemether-lumefantrine in HIV and malaria mono- and co-infections: a pharmacogenetic analysis from Ghana.多替拉韦与蒿甲醚-本芴醇在HIV和疟疾单一感染及合并感染中的药物相互作用:来自加纳的药物遗传学分析
AIDS Res Ther. 2025 Aug 30;22(1):85. doi: 10.1186/s12981-025-00787-9.
2
Malaria an opportunistic infection in HIV/AIDS patients? - A Nigerian experience.疟疾是艾滋病毒/艾滋病患者的机会性感染?——尼日利亚的经验。
Afr J Lab Med. 2022 Nov 24;11(1):1842. doi: 10.4102/ajlm.v11i1.1842. eCollection 2022.
3
Should we care about Plasmodium vivax and HIV co-infection? A systematic review and a cases series from the Brazilian Amazon.
我们是否应该关注间日疟原虫和 HIV 合并感染?来自巴西亚马逊地区的系统评价和病例系列。
Malar J. 2021 Jan 6;20(1):13. doi: 10.1186/s12936-020-03518-9.
4
PREVALENCE AND CLINICAL FORMS OF MALARIA AMONG FEBRILE HIV-INFECTED CHILDREN SEEN AT USMANU DANFODIYO UNIVERSITY TEACHING HOSPITAL, SOKOTO, NIGERIA.尼日利亚索科托乌斯曼努·丹福迪奥大学教学医院收治的发热艾滋病毒感染儿童中疟疾的患病率及临床类型
Afr J Infect Dis. 2020 Jan 8;14(1):24-32. doi: 10.21010/ajid.v14i1.4. eCollection 2020.
5
Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by c.516G>T Genotypes.个体 c.516G>T 基因型分层时奈韦拉平对青蒿琥酯- 双氢青蒿素药代动力学的差异影响。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.00947-19.
6
SIV infection aggravates malaria in a Chinese rhesus monkey coinfection model.SIV 感染加重中国猕猴混合感染疟疾模型中的疟疾。
BMC Infect Dis. 2019 Nov 12;19(1):965. doi: 10.1186/s12879-019-4465-6.
7
Malaria care-seeking behaviour among HIV-infected patients receiving antiretroviral treatment in South-Eastern Nigeria: A cross-sectional study.在尼日利亚东南部接受抗逆转录病毒治疗的 HIV 感染患者中寻求疟疾治疗的行为:一项横断面研究。
PLoS One. 2019 May 9;14(5):e0213742. doi: 10.1371/journal.pone.0213742. eCollection 2019.
8
Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction?青蒿琥酯-咯萘啶对奈韦拉平处置的药物遗传学影响:具有临床显著性的药物-药物相互作用?
Br J Clin Pharmacol. 2019 Mar;85(3):540-550. doi: 10.1111/bcp.13821. Epub 2019 Jan 2.
9
Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.原发性免疫缺陷患者的新发感染及与旅行相关的相关感染
J Clin Immunol. 2017 Oct;37(7):650-692. doi: 10.1007/s10875-017-0426-2. Epub 2017 Aug 7.
10
Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.乌干达与艾滋病毒/艾滋病相关的机会性感染的频率和分布模式。
BMC Res Notes. 2016 Dec 7;9(1):501. doi: 10.1186/s13104-016-2317-7.